The Lancet. Respiratory medicine Journal

Overview
Identity
View All

publication venue for

Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial.. 12:599-607. 2024
Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial.. 12:608-618. 2024
Early mobilisation during critical illness: good for the body and brain.. 11:500-502. 2023
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.. 11:329-340. 2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.. 10:888-899. 2022
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.. 9:239-250. 2021
Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?. 9:207-216. 2020
Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial.. 9:186-195. 2020
Immunotherapies for COVID-19: lessons learned from sepsis.. 8:946-949. 2020
Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study.. 6:213-222. 2018
Serum eosinophils as a COPD biomarker: ready for prime time?. 4:341-3. 2016
Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study.. 2:369-79. 2014